PT - JOURNAL ARTICLE AU - E. GIANNOPOULOU AU - P. RAVAZOULA AU - H. KALOFONOS AU - TH. MAKATSORIS AU - D. KARDAMAKIS TI - Expression of HIF-1α and iNOS in Astrocytic Gliomas: A Clinicopathological Study DP - 2006 May 01 TA - In Vivo PG - 421--425 VI - 20 IP - 3 4099 - http://iv.iiarjournals.org/content/20/3/421.short 4100 - http://iv.iiarjournals.org/content/20/3/421.full SO - In Vivo2006 May 01; 20 AB - Background: Hypoxia-inducible-factor-1 (HIF-1) is present at high levels in human tumors and plays a crucial role in tumor promotion by up-regulating several target genes. HIF-1 stimulates the production of NO through the induction of inducible NO synthase (iNOS). Patients and Methods: Sixty-three human astrocytic gliomas were analyzed by immunohistochemistry for HIF-1α and iNOS using formalin-fixed paraffin-embedded material. In 39 cases, the results of immunohistochemistry were correlated with the clinical outcomes. Results: HIF-1α was detected only in astrocytic gliomas grades III and IV, both in the nucleus and in the cytoplasm. The iNOS expression was increased in astrocytic gliomas grades I, II and III and was statistically significantly decreased in astrocytic gliomas grade IV. iNOS was localized round the capillary vessels as well. Statistical analysis showed that the HIF-1α and iNOS expressions did not correlate with patient survival. Conclusion: We believe that HIF-1α and iNOS expressions merit further investigations in order to understand the biology of astrocytic gliomas. More data are needed from prospective studies. Copyright © 2006 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved